Relative Bioavailability Study of MELT-100, IV Midazolam, and IV Ketamine

NCT04767035 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

25

Enrollment

INDUSTRY

Sponsor class

Conditions

Procedural Sedation

Interventions

DRUG: midazolam / ketamine sublingual tablet

Sponsor

Melt Pharmaceuticals

Collaborators

[object Object]